Paragon Capital Management (Utah)’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-14,857
Closed -$1.64M 69
2024
Q3
$1.64M Buy
14,857
+99
+0.7% +$10.4K 1.21% 31
2024
Q2
$1.45M Buy
14,758
+99
+0.7% +$10.1K 1.11% 39
2024
Q1
$1.64M Buy
14,659
+563
+4% +$60.7K 1.23% 37
2023
Q4
$1.42M Sell
14,096
-738
-5% -$73.2K 1.14% 36
2023
Q3
$1.29M Buy
+14,834
New +$1.34M 1.1% 36
2023
Q2
Sell
-15,043
Closed -$1.14M 72
2023
Q1
$1.14M Buy
+15,043
New +$1.13M 0.99% 40

Other funds holding CAH

Paragon Capital Management (Utah)'s CAH Position: Q4 2024 in Review

Paragon Capital Management (Utah) sold out of Cardinal Health (CAH) in Q4 2024, closing a stake of 14,857 shares — an estimated $1.64M sold.

Paragon Capital Management (Utah) first reported a position in CAH in Q1 2023 and held it in 6 quarters. The position peaked at $1.64M in Q3 2024. 1,097 funds tracked by Wall St. Rank hold CAH as of Q4 2024.

  • Paragon Capital Management (Utah) reported no remaining Cardinal Health position as of Q4 2024 after selling out during the quarter.
  • Paragon Capital Management (Utah) sold 14,857 Cardinal Health shares in Q4 2024, an estimated $1.64M.
  • Paragon Capital Management (Utah) first reported a position in Cardinal Health in Q1 2023 and held it in 6 quarters.
  • Paragon Capital Management (Utah)'s Cardinal Health position peaked at $1.64M in Q3 2024.
  • 1,097 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2024.

Based on Paragon Capital Management (Utah)'s 13F filing for Q4 2024, filed 27 Jan 2025.